Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers.

Breast disease - 1 Jan 2023

Seki Akina, Tsunoda Hiroko, Takei Junko, Suzuki Misato, Kanomata Naoki, Yamauchi Hideko

Abstract excerpt

BACKGROUND: BRCA1/2-associated invasive breast cancer has been extensively studied. However, there are few reports of ductal carcinoma in situ (DCIS). OBJECTIVE: This study aimed to investigate the clinicopathological and imaging findings of DCIS in patients with BRCA1/2 mutations. METHODS: This was a single-institution, retrospective study. We identified patients diagnosed with DCIS with BRCA mutations between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to Breast Neoplasms
Share to Carcinoma, Intraductal, Noninfiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Mastectomy

Share to Mutation

Source

Identifiers

PMID: 36806499
DOI: 10.3233/BD-220006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers.PMID 36806499Read ↗

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers.Semantic proximity Read ↗

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancerSemantic proximity Read ↗

Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma.Semantic proximity Read ↗

Ductal carcinoma in situ in BRCA mutation carriers.Semantic proximity Read ↗

Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.Semantic proximity Read ↗

Imaging Characteristics of Breast Cancers Detected During MRI-Based Surveillance in Hereditary Breast and Ovarian Cancer SyndromeSemantic proximity Read ↗

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.Semantic proximity Read ↗

MRI phenotypes associated with breast cancer predisposing genetic variants, a multisite review.Semantic proximity Read ↗

Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.Semantic proximity Read ↗

BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.Semantic proximity Read ↗

Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.